Cellular uptake mechanism and intracellular fate of hydrophobically modified glycol chitosan nanoparticles

Hae Yun Nam, Seok Min Kwon, Hyunjin Chung, Seung Young Lee, Seung Hae Kwon, Hyesung Jeon, Yoonkyung Kim, Jae Hyung Park, Joon Kim, Songwook Her, Yu Kyoung Oh, Ick Chan Kwon, Kwang Meyung Kim, Seo Young Jeong

Research output: Contribution to journalArticle

406 Citations (Scopus)

Abstract

Polymeric nanoparticle-based carriers are promising agents for the targeted delivery of therapeutics to the intracellular site of action. To optimize the efficacy in delivery, often the tuning of physicochemical properties (i.e., particle size, shape, surface charge, lipophilicity, etc.) is necessary, in a manner specific to each type of nanoparticle. Recent studies showed an efficient tumor targeting by hydrophobically modified glycol chitosan (HGC) nanoparticles through the enhanced permeability and retention (EPR) effect. As a continued effort, here the investigations on the cellular uptake mechanism and the intracellular fate of the HGC nanoparticles are reported. The HGC nanoparticle, prepared by a partial derivatization of the free amino groups of glycol chitosan (GC) with 5β-cholanic acid, had a globular shape with the average diameter of 359 nm and the zeta potential of ca. 22 mV. Interestingly, these nanoparticles showed an enhanced distribution in the whole cells, compared to the parent hydrophilic GC polymers. In vitro experiments with endocytic inhibitors suggested that several distinct uptake pathways (e.g., clathrin-mediated endocytosis, caveolae-mediated endocytosis, and macropinocytosis) are involved in the internalization of HGC. Some HGC nanoparticles were found entrapped in the lysosomes upon entry, as determined by TEM and colocalization studies. Given such favorable properties including low toxicity, biocompatibility, and fast uptake by several nondestructive endocytic pathways, our HGC nanoparticles may serve as a versatile carrier for the intracellular delivery of therapeutic agents.

Original languageEnglish
Pages (from-to)259-267
Number of pages9
JournalJournal of Controlled Release
Volume135
Issue number3
DOIs
Publication statusPublished - 2009 May 5

Fingerprint

Nanoparticles
Endocytosis
Caveolae
Clathrin
glycol-chitosan
Lysosomes
Particle Size
Permeability
Polymers
Therapeutics
Neoplasms

Keywords

  • Drug delivery system
  • Endocytosis
  • Hydrophobically modified glycol chitosan
  • Intracellular trafficking
  • Self-assembled nanoparticles

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Cellular uptake mechanism and intracellular fate of hydrophobically modified glycol chitosan nanoparticles. / Nam, Hae Yun; Kwon, Seok Min; Chung, Hyunjin; Lee, Seung Young; Kwon, Seung Hae; Jeon, Hyesung; Kim, Yoonkyung; Park, Jae Hyung; Kim, Joon; Her, Songwook; Oh, Yu Kyoung; Kwon, Ick Chan; Kim, Kwang Meyung; Jeong, Seo Young.

In: Journal of Controlled Release, Vol. 135, No. 3, 05.05.2009, p. 259-267.

Research output: Contribution to journalArticle

Nam, HY, Kwon, SM, Chung, H, Lee, SY, Kwon, SH, Jeon, H, Kim, Y, Park, JH, Kim, J, Her, S, Oh, YK, Kwon, IC, Kim, KM & Jeong, SY 2009, 'Cellular uptake mechanism and intracellular fate of hydrophobically modified glycol chitosan nanoparticles', Journal of Controlled Release, vol. 135, no. 3, pp. 259-267. https://doi.org/10.1016/j.jconrel.2009.01.018
Nam, Hae Yun ; Kwon, Seok Min ; Chung, Hyunjin ; Lee, Seung Young ; Kwon, Seung Hae ; Jeon, Hyesung ; Kim, Yoonkyung ; Park, Jae Hyung ; Kim, Joon ; Her, Songwook ; Oh, Yu Kyoung ; Kwon, Ick Chan ; Kim, Kwang Meyung ; Jeong, Seo Young. / Cellular uptake mechanism and intracellular fate of hydrophobically modified glycol chitosan nanoparticles. In: Journal of Controlled Release. 2009 ; Vol. 135, No. 3. pp. 259-267.
@article{dc2b56517fd34b8490ac7d3bd5cb0e78,
title = "Cellular uptake mechanism and intracellular fate of hydrophobically modified glycol chitosan nanoparticles",
abstract = "Polymeric nanoparticle-based carriers are promising agents for the targeted delivery of therapeutics to the intracellular site of action. To optimize the efficacy in delivery, often the tuning of physicochemical properties (i.e., particle size, shape, surface charge, lipophilicity, etc.) is necessary, in a manner specific to each type of nanoparticle. Recent studies showed an efficient tumor targeting by hydrophobically modified glycol chitosan (HGC) nanoparticles through the enhanced permeability and retention (EPR) effect. As a continued effort, here the investigations on the cellular uptake mechanism and the intracellular fate of the HGC nanoparticles are reported. The HGC nanoparticle, prepared by a partial derivatization of the free amino groups of glycol chitosan (GC) with 5β-cholanic acid, had a globular shape with the average diameter of 359 nm and the zeta potential of ca. 22 mV. Interestingly, these nanoparticles showed an enhanced distribution in the whole cells, compared to the parent hydrophilic GC polymers. In vitro experiments with endocytic inhibitors suggested that several distinct uptake pathways (e.g., clathrin-mediated endocytosis, caveolae-mediated endocytosis, and macropinocytosis) are involved in the internalization of HGC. Some HGC nanoparticles were found entrapped in the lysosomes upon entry, as determined by TEM and colocalization studies. Given such favorable properties including low toxicity, biocompatibility, and fast uptake by several nondestructive endocytic pathways, our HGC nanoparticles may serve as a versatile carrier for the intracellular delivery of therapeutic agents.",
keywords = "Drug delivery system, Endocytosis, Hydrophobically modified glycol chitosan, Intracellular trafficking, Self-assembled nanoparticles",
author = "Nam, {Hae Yun} and Kwon, {Seok Min} and Hyunjin Chung and Lee, {Seung Young} and Kwon, {Seung Hae} and Hyesung Jeon and Yoonkyung Kim and Park, {Jae Hyung} and Joon Kim and Songwook Her and Oh, {Yu Kyoung} and Kwon, {Ick Chan} and Kim, {Kwang Meyung} and Jeong, {Seo Young}",
year = "2009",
month = "5",
day = "5",
doi = "10.1016/j.jconrel.2009.01.018",
language = "English",
volume = "135",
pages = "259--267",
journal = "Journal of Controlled Release",
issn = "0168-3659",
publisher = "Elsevier",
number = "3",

}

TY - JOUR

T1 - Cellular uptake mechanism and intracellular fate of hydrophobically modified glycol chitosan nanoparticles

AU - Nam, Hae Yun

AU - Kwon, Seok Min

AU - Chung, Hyunjin

AU - Lee, Seung Young

AU - Kwon, Seung Hae

AU - Jeon, Hyesung

AU - Kim, Yoonkyung

AU - Park, Jae Hyung

AU - Kim, Joon

AU - Her, Songwook

AU - Oh, Yu Kyoung

AU - Kwon, Ick Chan

AU - Kim, Kwang Meyung

AU - Jeong, Seo Young

PY - 2009/5/5

Y1 - 2009/5/5

N2 - Polymeric nanoparticle-based carriers are promising agents for the targeted delivery of therapeutics to the intracellular site of action. To optimize the efficacy in delivery, often the tuning of physicochemical properties (i.e., particle size, shape, surface charge, lipophilicity, etc.) is necessary, in a manner specific to each type of nanoparticle. Recent studies showed an efficient tumor targeting by hydrophobically modified glycol chitosan (HGC) nanoparticles through the enhanced permeability and retention (EPR) effect. As a continued effort, here the investigations on the cellular uptake mechanism and the intracellular fate of the HGC nanoparticles are reported. The HGC nanoparticle, prepared by a partial derivatization of the free amino groups of glycol chitosan (GC) with 5β-cholanic acid, had a globular shape with the average diameter of 359 nm and the zeta potential of ca. 22 mV. Interestingly, these nanoparticles showed an enhanced distribution in the whole cells, compared to the parent hydrophilic GC polymers. In vitro experiments with endocytic inhibitors suggested that several distinct uptake pathways (e.g., clathrin-mediated endocytosis, caveolae-mediated endocytosis, and macropinocytosis) are involved in the internalization of HGC. Some HGC nanoparticles were found entrapped in the lysosomes upon entry, as determined by TEM and colocalization studies. Given such favorable properties including low toxicity, biocompatibility, and fast uptake by several nondestructive endocytic pathways, our HGC nanoparticles may serve as a versatile carrier for the intracellular delivery of therapeutic agents.

AB - Polymeric nanoparticle-based carriers are promising agents for the targeted delivery of therapeutics to the intracellular site of action. To optimize the efficacy in delivery, often the tuning of physicochemical properties (i.e., particle size, shape, surface charge, lipophilicity, etc.) is necessary, in a manner specific to each type of nanoparticle. Recent studies showed an efficient tumor targeting by hydrophobically modified glycol chitosan (HGC) nanoparticles through the enhanced permeability and retention (EPR) effect. As a continued effort, here the investigations on the cellular uptake mechanism and the intracellular fate of the HGC nanoparticles are reported. The HGC nanoparticle, prepared by a partial derivatization of the free amino groups of glycol chitosan (GC) with 5β-cholanic acid, had a globular shape with the average diameter of 359 nm and the zeta potential of ca. 22 mV. Interestingly, these nanoparticles showed an enhanced distribution in the whole cells, compared to the parent hydrophilic GC polymers. In vitro experiments with endocytic inhibitors suggested that several distinct uptake pathways (e.g., clathrin-mediated endocytosis, caveolae-mediated endocytosis, and macropinocytosis) are involved in the internalization of HGC. Some HGC nanoparticles were found entrapped in the lysosomes upon entry, as determined by TEM and colocalization studies. Given such favorable properties including low toxicity, biocompatibility, and fast uptake by several nondestructive endocytic pathways, our HGC nanoparticles may serve as a versatile carrier for the intracellular delivery of therapeutic agents.

KW - Drug delivery system

KW - Endocytosis

KW - Hydrophobically modified glycol chitosan

KW - Intracellular trafficking

KW - Self-assembled nanoparticles

UR - http://www.scopus.com/inward/record.url?scp=63649092083&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=63649092083&partnerID=8YFLogxK

U2 - 10.1016/j.jconrel.2009.01.018

DO - 10.1016/j.jconrel.2009.01.018

M3 - Article

VL - 135

SP - 259

EP - 267

JO - Journal of Controlled Release

JF - Journal of Controlled Release

SN - 0168-3659

IS - 3

ER -